Log In
Print
BCIQ
Print
Print this Print this
 

TAS266

  Manage Alerts
Collapse Summary General Information
Company Ablynx N.V.
DescriptionTetrameric Nanobody agonist targeting tumor necrosis factor (TNF) receptor superfamily member 10b (TNFRSF10B; DR5; TRAILR2; CD262)
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 10b (TNFRSF10B) (DR5) (TRAILR2) (CD262)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today